Firebrick Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:FRE Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
05 Mar 25	BuyAU$1,099,984	Pharma Nutria N.a. (metro Manila Luzon), Inc.	Company		11,578,947	AU$0.095

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of FRE?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	44,932,660	20%
Individual Insiders	75,513,401	33.6%
General Public	104,130,394	46.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 18 shareholders own 53.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.2%	Peter Molloy	31,811,017	AU$2.0m	0%	no data
13.8%	Stephen Goodall	31,038,290	AU$1.9m	0%	no data
11%	Gz Family Holdings Pty Ltd	24,600,000	AU$1.5m	0%	no data
5.16%	Pharma Nutria N.a. (metro Manila Luzon), Inc.	11,578,947	AU$717.9k	0%	no data
1.22%	Helen Morgan	2,744,507	AU$170.2k	0%	no data
1.14%	Ivan Kaufman	2,550,000	AU$158.1k	0%	no data
0.94%	Kashflow 18 Llc	2,103,713	AU$130.4k	0%	no data
0.92%	Ian Robertson	2,074,129	AU$128.6k	0%	no data
0.78%	The Shed Man Pty Ltd	1,750,000	AU$108.5k	0%	no data
0.67%	GB & JK Porter Pty Ltd	1,500,000	AU$93.0k	0%	no data
0.56%	Michelle Dalitz	1,250,000	AU$77.5k	0%	no data
0.56%	Jonathan Dalitz	1,250,000	AU$77.5k	0%	no data
0.53%	Greenford Pty Ltd	1,200,000	AU$74.4k	0%	no data
0.53%	GZ Super Investments Pty Ltd	1,200,000	AU$74.4k	0%	no data
0.53%	Jill Margo	1,183,100	AU$73.4k	0%	no data
0.45%	Michael Duckworth	1,012,358	AU$62.8k	0%	no data
0.45%	Davivaro Pty Ltd	1,000,000	AU$62.0k	0%	no data
0.27%	Phyllis Gardner	600,000	AU$37.2k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/07/18 20:20
End of Day Share Price	2025/07/18 00:00
Earnings	2024/12/31
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Firebrick Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.